Author (Study) | Year | Intervention | Dosage of treatment | Duration (yr) | Number of patients | Follow-up (mo) |
---|---|---|---|---|---|---|
Gnant (ABCSG12) | 2009 | Zoledronic acid No treatment | 4 mg IV every 6 months | 3 | 899 904 | 47.8 |
Shapiro (CALGB) | 2011 | Zoledronic acid No treatment | 4 mg IV every 3 months | NA | 70 80 | 12 |
Hershman | 2008 | Zoledronic acid Placebo | 4 mg IV every 3 months | 1 | 50 53 | 12 |
Coleman (AZURE) | 2011 | Zoledronic acid No treatment | 4 mg IV monthly for 6 months, then every 3 months for 8 doses and then every 6 months for 5 doses | 5 | 1665 1675 | 6 |
Brufsky (Z-FAST) | 2009 | Upfront zoledronic acid Delayed zoledronci acid | 4 mg IV every 6 months | 5 | 300 300 | 36 |
Eidtmann (ZO-FAST) | 2010 | Upfront zoledronic acid Delayed zoledronci acid | 4 mg IV every 6 months | 5 | 524 536 | 36 |
Hines (N03CC) | 2009 | Upfront zoledronic acid Delayed zoledronci acid | 4 mg IV every 6 months | 5 | 267 274 | 12 |